Coronary Artery Disease Progression Clinical Trial
Official title:
Plaque Reversal With Early, Aggressive Lipid Lowering Therapy
This study evaluates whether plaques in young patients with familial hypercholesterolemia (aged below 50 years) are susceptible to significant plaque regression with early, intensive lipid lowering therapy.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05462262 -
Intensive Lipid-lowering for Plaque and Major Adverse Cardiovascular Events in Low to Intermediate 10-year ASCVD Risk Population
|
N/A | |
| Not yet recruiting |
NCT06040073 -
Natural History of Coronary Atherosclerosis
|
||
| Active, not recruiting |
NCT03349385 -
Registry of Secondary Revascularization
|
||
| Recruiting |
NCT05860400 -
Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study
|
||
| Completed |
NCT03540381 -
Relation Among HDL Functionality, Neoatherosclerosis and Target Lesion Revascularization
|
||
| Completed |
NCT03192579 -
Effect of Rosuvastatin and Eicosapentaenoic Acid on Neoatherosclerosis: The LINK-IT Trial
|
Phase 4 | |
| Completed |
NCT03195621 -
Critical Treatment of Coronary Artery Disease
|
N/A | |
| Recruiting |
NCT05800093 -
Proteomics and Genomics Combined With CT to Predict CVD
|
||
| Recruiting |
NCT03533959 -
To Evaluate the Efficacy of Alirocumab for Neoatherosclerosis by Using OCT, in Comparison With Standard Statin Therapy
|
||
| Recruiting |
NCT04772768 -
Prior CABG Patients Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease
|
||
| Not yet recruiting |
NCT06007248 -
Disease Characteristics of IR-CAD: a Case-control Study
|
||
| Recruiting |
NCT03943459 -
Sirtuin-1 and Advanced Glycation End-products in Postmenopausal Women With Coronary Disease
|
Phase 3 | |
| Recruiting |
NCT03788369 -
Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization
|